As the number of Vioxx-related cases mounts, Merck is discovering that some of its insurers don’t want to pay for the company’s defense against the lawsuits. Merck says it will fight the insurers’ efforts to reduce or eliminate coverage. Merck disclosed the insurance battle Friday after markets had closed. It didn’t identify the insurance carriers or discuss how much coverage is at stake, according to a document filed with the Securities and Exchange Commission.
As the number of Vioxx-related cases mounts, Merck (MRK:NYSE – commentary – research) is discovering that some of its insurers don’t want to pay for the company’s defense against the lawsuits. Merck says it will fight the insurers’ efforts to reduce or eliminate coverage. Merck disclosed the insurance battle Friday after markets had closed. It […]